Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 40,065 shares at $135.07 ($5.5M) on 2017-01-05, disclosed to the SEC on 2017-01-09.
Seasonal sale ($5.5M) by Director — this insider has traded ALXN in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $134.90 | 334 | $45K | 0.8% |
| 2 | $135.07 | 17,105 | $2.3M | 41.6% |
| 3 | $139.90 | 334 | $47K | 0.8% |
| 4 | $139.98 | 17,105 | $2.4M | 43.2% |
| 5 | $144.90 | 334 | $48K | 0.9% |
| 6 | $144.93 | 4,853 |
| $703K |
| 12.7% |
| Total | $138.48 avg | 40,065 | $5.5M | 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2016-11-07 | $5.2M | — | Filing → |